EhsanSadriMDFACS (He/Him)

[Pronunciation: essan ]

Ophthalmology • Newport Beach, CA

Cornea & External Disease, Glaucoma Related, Oculo-Plastic & Orbital Reconstructive Surgery

Visionary Eye Institute

Join to view full profile

Dr. Sadri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sadri's full profile

Already have an account?

Office
361 Hospital Road
Suite 324
Newport Beach, CA 92663
Phone+1 949-528-3608

Summary

Dr. Ehsan Sadri is an ophthalmologist in Newport Beach, CA and is affiliated with multiple hospitals in the area, including AHMC Anaheim Regional Medical Center, Hoag Hospital - Irvine, Hoag Memorial Hospital Presbyterian, Providence Little Company of Mary Medical Center - Torrance, MemorialCare, Long Beach Memorial Medical Center, MemorialCare, Orange Coast Memorial Medical Center, Providence Little Company of Mary Medical Center San Pedro, and St. Mary Medical Center. He received his medical degree from University of Michigan Medical School and has been in practice 17 years. He also speaks multiple languages, including Spanish, French, and Farsi. He specializes in cornea & external disease, glaucoma related, and oculo-plastic & orbital reconstructive surgery and is experienced in sjogren's syndrome, blepharoplasty, glaucoma and related disorders, ophthalmic trauma, and refractive surgery.

Education & Training

University of MarylandResidency, Ophthalmology, 2001 - 2004
Arrowhead Regional Medical CenterInternship, Transitional Year, 2000 - 2001
University of Michigan Medical SchoolClass of 2000

Certifications & Licensure

CA State Medical License 2004 - 2026
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction Start of enrollment: 2022 Sep 19
Completed
Not Applicable
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma Start of enrollment: 2022 Feb 09
Recruiting
Not Applicable
Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Start of enrollment: 2014 Oct 01
Completed
Phase 3
Azelaic Acid on Demodex Counts in Rosacea Start of enrollment: 2010 Dec 01
Completed
Phase 2, Phase 3
Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Start of enrollment: 2020 Sep 09
Completed
Phase 2, Phase 3
Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Start of enrollment: 2021 Apr 29
Completed
Phase 3
Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers Start of enrollment: 2023 Dec 27
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

Effectiveness and safety of a thermo-mechanical action device versus thermal pulsation device in the treatment of meibomian gland dysfunction.
Ehsan Sadri, Anthony Verachtert, Gregory D Parkhurst, Julio Echegoyen, Ifat Klein
Journal of Cataract and Refractive Surgery. 2024-12-16
Rotational stability and visual performance of aberration-free, hydrophobic acrylic monofocal toric intraocular lens with enhanced material.
William F Wiley, Alice T Epitropoulos, Jeffrey Whitman, Eva Liang, Ehsan Sadri
Journal of Cataract and Refractive Surgery. 2024-12-01
1 citations
Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.
Ehsan Sadri, James D Paauw, Joseph B Ciolino, Lisa Nijm, Blake Simmons
Cornea. 2024-11-01

Authored Content

The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic SignJanuary 2022

Press Mentions

$Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive Surgery$
Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive SurgeryMay 1st, 2019
Ophthalmology Technology Summit 2018 Poised to Foster New Breakthroughs and Valuable CollaborationsApril 30th, 2018
$The Current Cataract Refractive Landscape$
The Current Cataract Refractive LandscapeSeptember 20th, 2018

Research History

Principle InvestigatorPresently conducting trials1995 - 2023

Professional Memberships

Other Languages

Spanish, French, Farsi

Industry Relationships

Consultant, AllerganDisclosure: Speaking